Leucine Rich Bio

Leucine Rich Bio is a biotechnology company headquartered in Bengaluru, India, that specializes in microbiome research, diagnostics, and therapeutics. Founded in 2014, the company utilizes its proprietary genomics-based platform to analyze gut microbial data, which it applies to preventive healthcare and precision medicine. Its primary offerings include BugSpeaks, a non-invasive gut microbiome test that assesses disease susceptibility and provides personalized nutritional recommendations, and Rychbiome, a nutraceutical brand that develops synbiotics derived from Indian gut microbiota data. The company leverages expertise in bioinformatics, biology, and data science to develop its intellectual property, which includes patent-pending interpretation engines and curated databases for microbiome analysis.

These solutions are designed to help individuals, healthcare providers, and nutritionists understand the link between gut health and overall wellness, addressing conditions such as obesity and type-2 diabetes through data-driven dietary and supplement interventions. The company has gained industry recognition, receiving awards such as the Government of India’s National Startup Award in the Health and Wellness sector and Frost & Sullivan awards for its technological innovation in microbiome diagnostics. By partnering with international clinics and diagnostic networks, Leucine Rich Bio aims to advance global access to microbiome-based health solutions while continuing to conduct research into diagnostic formulations and microbial health markers.